CIK 0001677077 · <br>Emerging growth company
Alzamend Neuro, Inc.
Sign in to watch- Ticker
- ALZN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811822909
- Phone
- 844-722-6333
- Business address
- 480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
- RW Other RW
- DEFA14A Proxy Proxy Materials
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- NT 10-K Other NT 10-K
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- NT 10-Q Other NT 10-Q
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- CERT Other Certification
- 8-A12B Other Registration of Securities
- FWP Offering Free Writing Prospectus
- FWP Offering Free Writing Prospectus
Page 1 of 2 · 34 filings